INDRAPRASTHA MEDICAL CORPORATION Financial Statement Analysis
|
||
|
The Revenues of INDRAPRASTHA MEDICAL CORPORATION have increased by 8.97% YoY .
The Earnings Per Share (EPS) of INDRAPRASTHA MEDICAL CORPORATION has increased by 29.88 % YoY. |
||
INDRAPRASTHA MEDICAL CORPORATION Last 5 Annual Financial Results
[BOM: 532150|NSE : INDRAMEDCO]
| Standalone | Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 |
|---|---|---|---|---|---|
| Operating Income | ₹1,356 Cr | ₹1,245 Cr | ₹1,099 Cr | ₹888 Cr | ₹613 Cr |
| Expenses | ₹1,112 Cr | ₹1,051 Cr | ₹948 Cr | ₹774 Cr | ₹573 Cr |
| Operating Profit (Excl OI) | ₹244 Cr | ₹193 Cr | ₹151 Cr | ₹114 Cr | ₹40 Cr |
| Other Income | ₹23 Cr | ₹17 Cr | ₹10 Cr | ₹3.12 Cr | ₹0.68 Cr |
| Interest | ₹6.27 Cr | ₹4.06 Cr | ₹4.28 Cr | ₹3.41 Cr | ₹3.34 Cr |
| Depreciation | ₹44 Cr | ₹40 Cr | ₹39 Cr | ₹35 Cr | ₹33 Cr |
| Profit Before Tax | ₹216 Cr | ₹166 Cr | ₹117 Cr | ₹79 Cr | ₹4.29 Cr |
| Profit After Tax | ₹161 Cr | ₹124 Cr | ₹86 Cr | ₹59 Cr | ₹2.33 Cr |
| Earnings Per Share (Rs) | ₹17.56 | ₹13.52 | ₹9.40 | ₹6.39 | ₹0.25 |
| PAT Margin (%) | 11.87 | 9.96 | 7.84 | 6.60 | 0.38 |
| ROE(%) | 29.97 | 28.92 | 24.44 | 19.60 | 0.86 |
| ROCE(%) | 41.43 | 39.70 | 34.46 | 27.58 | 2.80 |
| Total Debt/Equity(x) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Key Financials |
||
| Market Cap | : | ₹ 3,696.4 Cr |
| Revenue (TTM) | : | ₹ 1,451.5 Cr |
| Net Profit(TTM) | : | ₹ 182.9 Cr |
| EPS (TTM) | : | ₹ 19.9 |
| P/E (TTM) | : | 20.2 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| INDRAPRASTHA MEDICAL CORPORATION | -1.8% | 12.9% | -0.5% |
| MAX HEALTHCARE INSTITUTE | 2% | 16.5% | 5.6% |
| APOLLO HOSPITALS ENTERPRISE | 2.2% | 14.4% | 21.7% |
| FORTIS HEALTHCARE | 4.8% | 14.5% | 52.7% |
| GLOBAL HEALTH | 2.7% | 12.3% | -4.2% |
| NARAYANA HRUDAYALAYA | 1.2% | 6.1% | 32.7% |
| KRISHNA INSTITUTE OF MEDICAL SCIENCES | 7.2% | 22.9% | 33.9% |
| DR LAL PATHLABS | 0.2% | 0.8% | 8.5% |
| ASTER DM HEALTHCARE | 2.9% | 20.5% | 53.9% |
INDRAPRASTHA MEDICAL CORPORATION Revenues
[BOM: 532150|NSE : INDRAMEDCO]
| Y-o-Y | 8.97 % |
| 5 Yr CAGR | 21.94 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,356 Cr | 8.97 | |
| Mar2024 | ₹1,245 Cr | 13.29 | |
| Mar2023 | ₹1,099 Cr | 23.70 | |
| Mar2022 | ₹888 Cr | 44.80 | |
| Mar2021 | ₹613 Cr | - | |
INDRAPRASTHA MEDICAL CORPORATION Operating Profit
[BOM: 532150|NSE : INDRAMEDCO]
| Y-o-Y | 26.33 % |
| 5 Yr CAGR | 56.94 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹244 Cr | 26.33 | |
| Mar2024 | ₹193 Cr | 28.31 | |
| Mar2023 | ₹151 Cr | 31.85 | |
| Mar2022 | ₹114 Cr | 183.83 | |
| Mar2021 | ₹40 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 15.97 % |
| 5 Yr CAGR | 28.67 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2025 | 18.01% | 15.97 | |
| Mar2024 | 15.53% | 13.19 | |
| Mar2023 | 13.72% | 6.60 | |
| Mar2022 | 12.87% | 95.89 | |
| Mar2021 | 6.57% | - | |
INDRAPRASTHA MEDICAL CORPORATION Profit After Tax
[BOM: 532150|NSE : INDRAMEDCO]
| Y-o-Y | 29.87 % |
| 5 Yr CAGR | 188.31 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹161 Cr | 29.87 | |
| Mar2024 | ₹124 Cr | 43.89 | |
| Mar2023 | ₹86 Cr | 46.96 | |
| Mar2022 | ₹59 Cr | 2,415.88 | |
| Mar2021 | ₹2.33 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 19.18 % |
| 5 Yr CAGR | 136.41 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2025 | 11.87 % | 19.18 | |
| Mar2024 | 9.96 % | 27.04 | |
| Mar2023 | 7.84 % | 18.79 | |
| Mar2022 | 6.6 % | 1,636.84 | |
| Mar2021 | 0.38 % | - | |
INDRAPRASTHA MEDICAL CORPORATION Earnings Per Share (EPS)
[BOM: 532150|NSE : INDRAMEDCO]
| Y-o-Y | 29.88 % |
| 5 Yr CAGR | 189.50 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2025 | ₹18 | 29.88 | |
| Mar2024 | ₹14 | 43.83 | |
| Mar2023 | ₹9.40 | 47.10 | |
| Mar2022 | ₹6.39 | 2,456.00 | |
| Mar2021 | ₹0.25 | - | |
INDRAPRASTHA MEDICAL CORPORATION Return on Capital Employed (ROCE)
[BOM: 532150|NSE : INDRAMEDCO]
| Y-o-Y | 4.36 % |
| 5 Yr CAGR | 96.13 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2025 | 41.43% | 4.36 | |
| Mar2024 | 39.7% | 15.21 | |
| Mar2023 | 34.46% | 24.95 | |
| Mar2022 | 27.58% | 885.00 | |
| Mar2021 | 2.8% | - | |
INDRAPRASTHA MEDICAL CORPORATION Share Price vs Sensex
| Current Share Price | : | ₹403.1 |
| Current MarketCap | : | ₹ 3,696.4 Cr |
| Updated EOD on | : | Feb 26,2026 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDRAPRASTHA MEDICAL CORPORATION | -1.8% |
12.9% |
-0.5% |
| SENSEX | -0.3% |
-0.1% |
8.3% |
INDRAPRASTHA MEDICAL CORPORATION related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE ALLCAP | 6.4% | 8.9% | 7.5% |
| BSE MIDSMALLCAP | 4.7% | 9% | 8.4% |
| BSE HEALTHCARE | 3.2% | 7.7% | 10.8% |
| BSE SMALLCAP | -5.8% | -8.9% | -10.5% |
No NSE index found
You may also like the below Video Courses
FAQ about INDRAPRASTHA MEDICAL CORPORATION Financials
How the annual revenues of INDRAPRASTHA MEDICAL CORPORATION have changed ?
The Revenues of INDRAPRASTHA MEDICAL CORPORATION have increased by 8.97% YoY .
How the Earnings per Share (EPS) of INDRAPRASTHA MEDICAL CORPORATION have changed?
The Earnings Per Share (EPS) of INDRAPRASTHA MEDICAL CORPORATION has increased by 29.88 % YoY .
Check out Intrinsic Value of Peers of INDRAPRASTHA MEDICAL CORPORATION
Compare Stock Analytics of Peers of INDRAPRASTHA MEDICAL CORPORATION
MAX HEALTHCARE INSTITUTE LTD vs APOLLO HOSPITALS ENTERPRISE LTD vs FORTIS HEALTHCARE LTD
GLOBAL HEALTH LTD vs NARAYANA HRUDAYALAYA LTD vs
MAX HEALTHCARE INSTITUTE LTD vs APOLLO HOSPITALS ENTERPRISE LTD vs FORTIS HEALTHCARE LTD
GLOBAL HEALTH LTD vs NARAYANA HRUDAYALAYA LTD vs
